CD4 and myasthenia gravis: The frequencies of cTfh (9.2% vs 3.3%, p < 0.001) and cTh17 (4.6% vs 1.7%, p = 0.005) among CD4+ T cells were significantly higher in MG patients than in HCs (Figures 2A, B).